Human immunodeficiency virus (HIV-1) is the major cause of acquired immunodeficiency syndrome (AIDS) in humans. The HIV- 1 envelope glycoproteins, gp120 and gp41, are contained in trimeric complexes on the virion surface. The gp120 envelope glycoprotein mediates virus attachment to target cell receptors, CD4 and the chemokine receptors, CCR5 or CXCR4. Receptor binding triggers conformational changes in the HIV-1 envelope glycoproteins leading to the fusion of the viral and target cell membranes, a process mediated by the gp41 transmembrane envelope glycoprotein. During natural infection, envelope glycoprotein- receptor interactions can potentially be interrupted by neutralizing antibodies directed against the gp120 glycoprotein or by chemokines. In addition, a number of small-molecular- weight inhibitors that bind to the chemokine receptors have been developed and some of these may proceed to clinical trials. In this application, a series of studies are proposed that will extend our knowledge of the interactions of chemokine receptors with HIV-1 gp120 and with the chemokines.
In Specific Aim 1, the CXCR4-binding sites on the gp120 glycoproteins of X4 and R5X4 HIV-1 isolates will be mapped, thus allowing comparison of the binding sites for CXCR4 and CCR5.
In Specific Aim 2, the mechanisms by which HIV-1 adapts to utilize wild-type and variant chemokine receptors in a CD4-independent fashion will be explored.
In Specific Aim 3, the mechanism of HIV-1 adaptation to drugs directed against CCR5 will be investigated.
In Specific Aim 4, the contribution of O-linked glycosylation to CCR5 function will be explored. Together, these studies will provide a comprehensive picture of the interactions of the CCR5 and CXCR4 chemokine receptors with key ligands.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI041851-08
Application #
6793658
Study Section
Special Emphasis Panel (ZRG1-AARR-1 (01))
Program Officer
Sharma, Opendra K
Project Start
1997-09-01
Project End
2007-08-31
Budget Start
2004-09-01
Budget End
2005-08-31
Support Year
8
Fiscal Year
2004
Total Cost
$427,500
Indirect Cost
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
076580745
City
Boston
State
MA
Country
United States
Zip Code
02215
Madani, Navid; Hubicki, Amy M; Perdigoto, Ana Luisa et al. (2007) Inhibition of human immunodeficiency virus envelope glycoprotein- mediated single cell lysis by low-molecular-weight antagonists of viral entry. J Virol 81:532-8
Schon, Arne; Madani, Navid; Klein, Jeffrey C et al. (2006) Thermodynamics of binding of a low-molecular-weight CD4 mimetic to HIV-1 gp120. Biochemistry 45:10973-80
Wang, Jianbin; Babcock, Gregory J; Choe, Hyeryun et al. (2004) N-linked glycosylation in the CXCR4 N-terminus inhibits binding to HIV-1 envelope glycoproteins. Virology 324:140-50
Gao, Jinming; Choe, Hyeryun; Bota, Dalena et al. (2003) Sulfation of tyrosine 174 in the human C3a receptor is essential for binding of C3a anaphylatoxin. J Biol Chem 278:37902-8
Stenlund, Peter; Babcock, Gregory J; Sodroski, Joseph et al. (2003) Capture and reconstitution of G protein-coupled receptors on a biosensor surface. Anal Biochem 316:243-50
Cavacini, Lisa; Duval, Mark; Song, Leslie et al. (2003) Conformational changes in env oligomer induced by an antibody dependent on the V3 loop base. AIDS 17:685-9
Xiang, Shi-Hua; Wang, Liping; Abreu, Mariam et al. (2003) Epitope mapping and characterization of a novel CD4-induced human monoclonal antibody capable of neutralizing primary HIV-1 strains. Virology 315:124-34
Yang, Xinzhen; Mahony, Erin; Holm, Geoff H et al. (2003) Role of the gp120 inner domain beta-sandwich in the interaction between the human immunodeficiency virus envelope glycoprotein subunits. Virology 313:117-25
Raja, Aarti; Venturi, Miro; Kwong, Peter et al. (2003) CD4 binding site antibodies inhibit human immunodeficiency virus gp120 envelope glycoprotein interaction with CCR5. J Virol 77:713-8
Labrijn, Aran F; Poignard, Pascal; Raja, Aarti et al. (2003) Access of antibody molecules to the conserved coreceptor binding site on glycoprotein gp120 is sterically restricted on primary human immunodeficiency virus type 1. J Virol 77:10557-65

Showing the most recent 10 out of 33 publications